Cheslack-Postava, Keely
Forthal, Sarah
Musa, George J.
Ryan, Megan
Bresnahan, Michaeline
Sapigao, Rosemarie G.
Lin, Susan
Fan, Bin
Svob, Connie
Geronazzo-Alman, Lupo
Hsu, Yi-ju
Skokauskas, Norbert
Hoven, Christina W.
Funding for this research was provided by:
National Institute on Drug Abuse (R01 DA038154-05S3)
Article History
Received: 4 January 2023
Accepted: 15 August 2023
First Online: 25 August 2023
Declarations
:
: The authors have no competing interests to declare that are relevant to the content of this article.
: All procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects/patients were approved by the institutional review board of the New York State Psychiatric Institute (protocol #8051).
: Informed consent was obtained from all individual participants included in the study.
: Meeting of the National Institute of Health—Social, Behavioral, and Economic (NIH–SBE) Health Impacts of COVID-19 webinar, online, April 27–28, 2022.